Autres langues 2cureX AB

Actions

2CUREX

SE0010468124

Marché Fermé - Nasdaq Stockholm Autres places de cotation 16:15:54 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,404 ^SEK	-16,53%		-9,42%	-79,90%

29/02	2curex AB (publ) élit Grith Hagel comme nouveau membre du conseil d'administration	CI
22/02	2cureX AB (publ) publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS	16/03
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	29/02
2curex AB Elects Grith Hagel as a New Board Member	29/02
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024	22/02
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	12/02
2cureX AB Announces Change to the Board of Directors	04/01
2cureX AB Announces CEO Changes	29/12
2cureX AB Announces Executive Changes, Effective 1 January 2024	29/12
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop	29/12
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12
2cureX publishes interim report for the third quarter of 2023	23/11
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	14/11
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman	14/11
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	26/10/23
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	25/10/23
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests	11/10/23
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation	30/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 2cureX AB

Actions

2CUREX

SE0010468124

Autres langues

Filtres